Test Your Knowledge of Ovarian Cancer

A 58-year-old female is diagnosed with stage III, recurrent high-grade endometrioid ovarian cancer. She proceeds to treatment of her relapse with carboplatin and paclitaxel and achieves a partial response. Based on the results of the ARIEL3 trial, which of the following is true regarding the use of rucaparib in this setting?